Protective Cellular Immune Response Induction for Cutaneous Leishmaniasis by a New Immunochemotherapy Schedule
The palladacycle complex DPPE 1.2 was previously shown to inhibit Leishmania (Leishmania) amazonensis infection in vitro and in vivo. The present study aimed to evaluate the effect of DPPE 1.2 associated with a recombinant cysteine proteinase, rLdccys1, and the adjuvant Propionibacterium acnes on L....
Main Authors: | Danielle A. M. da Silva, Fabiana R. Santana, Simone Katz, Daniel M. Garcia, Daniela Teixeira, Ieda M. Longo-Maugéri, Clara L. Barbiéri |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.00345/full |
Similar Items
-
Leishmanicidal and Immunomodulatory Activities of the Palladacycle Complex DPPE 1.1, a Potential Candidate for Treatment of Cutaneous Leishmaniasis
by: Isabela B. dos Santos, et al.
Published: (2018-07-01) -
Immunotherapy and immunochemotherapy in visceral leishmaniasis: promising treatments for this neglected disease
by: Bruno Mendes Roatt, et al.
Published: (2014-06-01) -
Cutaneous Leishmaniasis Vaccination: A Matter of Quality
by: Paula Mello De Luca, et al.
Published: (2016-04-01) -
Action of pentoxifylline on experimental cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis
by: Thiago de Sá Oliveira, et al.
Published: (2000-08-01) -
The role of natural killer cells in the early period of infection in murine cutaneous leishmaniasis
by: M.D. Laurenti, et al.
Published: (1999-03-01)